Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
to prevent the onset of cancer. In parallel, our research is dedicated to advancing our understanding of bladder tumor evolution biology through the analysis of next-generation sequencing (NGS) data and the
-
into hours, scale evidence review across thousands of studies, and explore many hypotheses in parallel so researchers and clinicians can focus on strategic decisions and patient care. Every solution you build
-
method, can engineer thousands of defined mutations in parallel in a single test tube in yeast. Strains are tagged by DNA barcodes, allowing to efficiently track mutations in cell populations during
-
, which also encompasses single-cell resolution spatial transcriptomics of human plaques to precisely identify and characterize disease-relevant smooth muscle cell phenotypes, a parallel track of organoid
-
. occupational pension plan and capital-forming payments 30 days of vacation per year Flexible working hours Possibility of part-time work Family-friendly working environment Sustainable travel to work
-
to understand cancer development and to develop new therapeutic strategies. The Fred Hutch/University of Washington Head and Neck Research Program- Fred Hutch and the University of Washington have a world-class
-
funded by the EU FP7 program, H2020 program and the European Space Agency (ESA). For further information, you may check: www.securityandtrust.lu The SigCom research group carries out research activities in
-
have a unique gene expression program and atypical chromosome segregation during mitosis; yet, the underlying mechanisms remain elusive. The goals are to elucidate the chromatin structure and associated
-
funded by the EU FP7 program, H2020 program and the European Space Agency (ESA). For further information, you may check: www.securityandtrust.lu The SigCom research group carries out research activities in
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
-malignant blood diseases, such as sickle cell disease, bone marrow failure syndromes, and myeloproliferative disorders. This premier NHLBI-sponsored T32 training program leverages the exceptional research